Pulmatrix Inc.

NASDAQ: PULMHealthcare / Biotechnology / USA
0.9100+0.0100+1.11%Vol 91 2801Y Perf -81.43%
Jul 22nd, 2019 15:07
BID0.9000 ASK0.9100
Open0.9200 Previous Close0.9000
Pre-Market0.89 After-Trading-
 - -%  - -%
Target Price
22.00 
Analyst Rating
Strong Buy 1.00
Potencial %
2 317.58 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)17 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
4.24 
Earnings Date
2nd Aug 2019

Today's Price Range

0.88000.9200

52wk Range

0.72005.20

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-1.09%
1 Month
-6.19%
3 Months
-14.15%
6 Months
-59.56%
1 Year
-81.43%
3 Years
-95.79%
5 Years
-99.28%
10 Years
-

Name / TickerPriceChg.Chg.%
PULM0.91000.01001.11
AAPL207.224.63002.29
GOOG1 138.077.97000.71
MSFT138.431.81001.32
XOM75.070.08000.11
WFC46.480.45000.98
JNJ128.64-1.6700-1.28
FB202.323.96002.00
GE10.210.17001.69
JPM114.270.73000.64
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.59-0.60-1.69
Q03 2018-1.40-1.0028.57
Q02 2018-1.90-1.3031.58
Q01 2018-1.80-2.40-33.33
Q04 2017--0.21-
Q03 2017-3.00-2.2026.67
Q02 2017-0.30-0.293.33
Q02 2016--0.34-
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.3911.36Positive
9/2019 QR-0.4011.11Positive
12/2019 FY-1.903.55Positive
12/2020 FY-1.730.00-
Next Report Date2nd Aug 2019
Estimated EPS Next Report-0.39
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume91 280
Shares Outstanding (in ths.)18 289
Trades Count103
Dollar Volume78 373
Avg. Volume1 161 071
Avg. Weekly Volume152 425
Avg. Monthly Volume193 581
Avg. Quarterly Volume462 165
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Pulmatrix Inc.

Pulmatrix Inc is a clinical stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.

CEO: Ted Raad

Teplephone: +1 781 357-2333

Address: 99 Hayden Avenue, Lexington 02421, MA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

63%37%

News